{"url":"https://whatshealthyandwhy.com/shatavari/womens-health-and-adaptogen","path":"/shatavari/womens-health-and-adaptogen","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/shatavari/womens-health-and-adaptogen.json","markdown":"https://whatshealthyandwhy.com/shatavari/womens-health-and-adaptogen.md"},"topic":{"slug":"shatavari","name":"Shatavari","url":"https://whatshealthyandwhy.com/shatavari"},"slug":"womens-health-and-adaptogen","order":1,"title":"Women's Health and Adaptogen","question":"Does shatavari help menopause symptoms and breast milk supply?","answer":"Shatavari likely reduces menopausal hot flashes and increases breast milk supply, but trials so far are small.","description":"How Shatavari supports hormonal balance, lactation, perimenopause, and stress resilience in women","confidence":3,"confidenceNote":"Five small RCTs agree on benefit (stated sizes 60–80 women), but the menopause trials need independent replication.","evidenceSummary":{"rctCount":5,"observationalCount":0,"metaAnalysisCount":0,"totalParticipants":"210+","replicated":true,"newestStudyYear":2025},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Herbs & Spices","subcategorySlug":"herbs","url":"https://whatshealthyandwhy.com/explore/good-for-you/herbs"},"actions":["Most trials used 500–600 mg a day of standardized root extract for 8 weeks or longer [1][2].","Take it as a capsule or as root powder stirred into warm milk, the traditional preparation.","Give it about 8 weeks before judging results; the menopause trials ran 8 weeks [1][2]."],"cautions":["Avoid it if you are allergic to asparagus, which is in the same botanical family.","It has phytoestrogenic activity; women with estrogen-receptor positive cancers should speak with their healthcare provider first.","Trials were small and about 8 weeks long; the side effects reported were mild stomach complaints."],"simpleText":"Shatavari (Asparagus racemosus) is an Ayurvedic herb that has been used for centuries as a tonic for women's reproductive health. Modern clinical trials have confirmed its ability to support lactation, reduce perimenopausal symptoms, and help the body manage stress — effects driven largely by its steroidal saponins, which have mild phytoestrogenic activity [1][5].\n\nIt is sometimes called the \"Queen of Herbs\" in Ayurvedic tradition, reflecting its central role as a female adaptogen. Contemporary randomized controlled trials show statistically significant benefits for hot flashes, night sweats, perceived stress, and breast milk production — all with a favorable safety profile.","mediumText":"How Shatavari Works\n\nThe root of Asparagus racemosus contains a family of active compounds called shatavarins — steroidal saponins that bind weakly to estrogen receptors and modulate estrogen-sensitive pathways without the risks associated with synthetic hormones [5]. This makes Shatavari a phytoestrogenic adaptogen: it can gently support estrogen-dependent functions when levels decline (perimenopause) or need fine-tuning.\n\nBeyond phytoestrogenic activity, Shatavari works on the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal cascade governing the stress response. Research shows it raises levels of brain-derived neurotrophic factor (BDNF) and modulates both monoaminergic (serotonin, dopamine) and GABAergic neurotransmitter systems [5]. This breadth of action is characteristic of a true adaptogen: it normalizes the body's stress response rather than suppressing or stimulating it in a single direction.\n\nKey Uses\n\nPerimenopause and menopause: Two recent randomized controlled trials found significant reductions in hot flash frequency, night sweats, anxiety, and sleep disturbance in women taking 500–600 mg/day of Shatavari root extract [1][2]. One trial also documented a significant increase in circulating estradiol (p = 0.003), supporting the phytoestrogenic mechanism [1].\n\nLactation support: Shatavari is one of the most-studied galactagogues (milk-promoting herbs). It appears to increase prolactin secretion, which drives breast milk production. Clinical trials show significant improvements in milk volume, time to breast fullness, and infant weight gain in breastfeeding mothers who took Shatavari [3][4].\n\nStress resilience: As an adaptogen, Shatavari modulates the HPA axis and supports emotional well-being under chronic stress. This is relevant beyond reproductive health: the same perimenopause trial that measured hot flashes also found a 7-point reduction in perceived stress scores in the Shatavari group, compared to a 3.8-point increase in the placebo group [1].\n\nDosage and Practical Notes\n\nMost clinical trials have used 500–600 mg/day of standardized root extract, typically taken for 8 weeks or longer. Traditional preparations include powder stirred into warm milk, though capsule supplements are more commonly used today.\n\nShatavari is considered safe for most women, with clinical trials reporting only mild gastrointestinal complaints. Women who are allergic to asparagus should avoid it (it is in the same botanical family). Given its phytoestrogenic activity, women with estrogen-receptor positive cancers should discuss use with their healthcare provider before taking it.\n\nCross-reference: For related adaptogen support, see our Ashwagandha page — which has stronger evidence for the male HPA axis and athletic performance — and the Maca Root page for another hormone-balancing Ayurvedic herb.","deepText":"Evidence Review\n\nPerimenopause: Hot Flashes, Mood, and Estradiol\n\nMahajan et al. (2025) conducted a randomized, double-blind, placebo-controlled trial in 80 perimenopausal women (73 completed per-protocol). Participants received Shatavari root extract or placebo for 8 weeks [1]. The primary outcome, the Menopause Rating Scale (MRS) total score, showed a mean reduction of 12.54 points in the Shatavari group versus 1.61 points in the placebo group (p < 0.0001). Hot flash frequency fell by 3.84 events per day in the treatment group versus 1.03 in controls (p = 0.002). Perceived stress (PSS-10) improved by 7.11 points in the Shatavari group versus a deterioration of 3.81 points in placebo (p < 0.0001). Serum estradiol increased significantly in the treatment group (p = 0.003), providing a mechanistic anchor for the symptom improvements. No adverse events were recorded.\n\nGudise et al. (2024) conducted an 8-week multicenter RCT in 70 menopausal women (35 per arm) [2]. The Utian Quality of Life (UQoL) total score increased by 35.13% in the Shatavari group versus minimal change in placebo (p < 0.0001). Hot flashes fell from a mean of 1.97 to 0.14 episodes per day in the treatment group versus 2.0 to 1.18 in placebo. Night sweats dropped from 0.77 to 0.06 per day in active subjects. Insomnia scale scores improved 41% with Shatavari versus a 19.56% increase (worsening) in the placebo group. Depression, anxiety, and stress scores all significantly improved (all p < 0.0001). Adverse events were mild and infrequent.\n\nTogether these trials provide converging evidence at two stages of hormonal transition, though both used the same root extract standardization and involved relatively small samples. Independent replication with larger cohorts is warranted.\n\nLactation: Prolactin and Infant Outcomes\n\nGupta and Shaw (2011) conducted a double-blind RCT in 60 lactating women (30 per group, mean age 25.6 years, infants averaging 2.8 months old) [3]. The Shatavari group showed a mean 32.87% increase in serum prolactin versus 9.56% in controls — approximately a threefold difference. Infant weight gain was 16.13% in the treatment group versus 5.68% in controls. Maternal satisfaction scores improved 1.54 points with Shatavari versus 0.48 points in controls. Infant well-being ratings similarly diverged significantly. All differences reached p < 0.05.\n\nSharma et al. (1996), in an earlier RCT, corroborated the lactation benefit, finding improved milk volumes and breast fullness times in mothers receiving Shatavari extract compared to placebo [6]. A 2025 RCT by Ajgaonkar et al. further replicated the postpartum lactation benefit with modern study design [4], suggesting the prolactin-elevating effect is robust across populations and formulations.\n\nThe proposed mechanism is stimulation of prolactin secretion via phytoestrogenic and dopaminergic pathways, though the precise receptor-level action has not been fully characterized in humans.\n\nAdaptogenic Mechanisms\n\nA 2023 narrative review by Singh et al. synthesized animal and clinical data on Shatavari's adaptogenic properties [5]. The authors describe modulation of the HPA axis with suppression of stress-induced cortisol excess, upregulation of BDNF (brain-derived neurotrophic factor) supporting neuroplasticity, and enhancement of antioxidant enzyme activity (SOD, GSH peroxidase, catalase) across brain regions. GABAergic and serotonergic modulation were highlighted as likely contributors to the anxiolytic and antidepressant effects observed in animal models.\n\nHuman clinical data on pure stress adaptation (outside the perimenopausal studies) is more limited, though enzyme-treated asparagus extract (a related preparation) has shown anti-stress and sleep quality benefits in small controlled trials. The animal data appears mechanistically consistent with the human hormonal studies, but head-to-head comparisons with well-validated adaptogens like ashwagandha are not yet available.\n\nOverall Evidence Assessment\n\nThe evidence for Shatavari's effects on lactation is moderately strong, supported by multiple independent RCTs across decades. The evidence for perimenopausal and menopausal symptom relief is promising, with two recent well-designed trials showing large effect sizes, though independent replication is still needed. The adaptogenic and stress-modulation evidence is mainly mechanistic and animal-based, with human data limited to secondary outcomes in hormonal trials. For women navigating perimenopause or supporting breastfeeding, Shatavari represents a well-tolerated option with a credible evidence base.","deepTruncated":false,"references":[{"id":"1","title":"Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: Randomized, Double-Blind, Placebo-Controlled Study","authors":"Mahajan S, Avad P, Langade J","year":2025,"journal":"International Journal of Women's Health","pmid":"41209045","url":"https://pubmed.ncbi.nlm.nih.gov/41209045/"},{"id":"2","title":"Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial","authors":"Gudise VS, Dasari MP, Kuricheti SSK","year":2024,"journal":"Cureus","pmid":"38725785","url":"https://pubmed.ncbi.nlm.nih.gov/38725785/"},{"id":"3","title":"A Double-Blind Randomized Clinical Trial for Evaluation of Galactogogue Activity of Asparagus racemosus Willd.","authors":"Gupta M, Shaw B","year":2011,"journal":"Iranian Journal of Pharmaceutical Research","pmid":"24363697","url":"https://pubmed.ncbi.nlm.nih.gov/24363697/"},{"id":"4","title":"Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study","authors":"Ajgaonkar A, Debnath T, Bhatnagar S, Debnath K, Langade J","year":2025,"journal":"Journal of Obstetrics and Gynaecology","pmid":"41055223","url":"https://pubmed.ncbi.nlm.nih.gov/41055223/"},{"id":"5","title":"Adaptogenic property of Asparagus racemosus: Future trends and prospects","authors":"Singh N, Garg M, Prajapati P, Singh PK, Chopra R, Kumari A, Mittal A","year":2023,"journal":"Heliyon","pmid":"37095959","url":"https://pubmed.ncbi.nlm.nih.gov/37095959/"},{"id":"6","title":"Randomized controlled trial of Asparagus racemosus (Shatavari) as a lactogogue in lactational inadequacy","authors":"Sharma S, Ramji S, Kumari S, Bapna JS","year":1996,"journal":"Indian Pediatrics","pmid":"8979551","url":"https://pubmed.ncbi.nlm.nih.gov/8979551/"}],"wordCount":1130,"source":{"path":"src/content/topics/shatavari/womens-health-and-adaptogen.md"},"citeAs":"“Does shatavari help menopause symptoms and breast milk supply?.” What's Healthy and Why. https://whatshealthyandwhy.com/shatavari/womens-health-and-adaptogen","notice":"General information backed by peer-reviewed research, not medical advice."}